By Year 
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo.
Hick, TAH; Geertsema, C; Nguyen, W; van Oosten, L; Bishop, CR; Abbo, SR; Dumenil, T; van Kuppeveld, FJM; Langereis, MA; Rawle, DJ; Tang, B; Yan, K; van Oers, MM; Suhrbier, A; Pijlman, GP
Molecular therapy : the journal of the American Society of Gene Therapy - 17/07/2024
Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung.
Bishop, CR; Yan, K; Nguyen, W; Rawle, DJ; Tang, B; Larcher, T; Suhrbier, A
Frontiers in Immunology - 13/06/2024
Generating prophylactic immunity against arboviruses in vertebrates and invertebrates.
Rawle, DJ; Hugo, LE; Cox, AL; Devine, GJ; Suhrbier, A
Nature reviews. Immunology - 3/05/2024
Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.
Lin, MH; Maniam, P; Li, D; Tang, B; Bishop, CR; Suhrbier, A; Earl, LW; Tayyar, Y; McMillan, NAJ; Li, L; Harrich, D
Molecular therapy. Nucleic acids - 12/01/2024
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.
Stewart, R; Yan, K; Ellis, SA; Bishop, CR; Dumenil, T; Tang, B; Nguyen, W; Larcher, T; Parry, R; Sng, JJ; Khromykh, AA; Sullivan, RKP; Lor, M; Meunier, FA; Rawle, DJ; Suhrbier, A
Frontiers in microbiology - 23/12/2023